The document protection for 15 years for an important medication for an orphan drug will only be given when an application is made for such. The extension of the document protection should be applied for with the new application for marketing autorisation (Application form section 6.3) according to the new guidelines of 1.1.2019 and if not then (for applications before 1.1.2019), then at the latest a year following approval of the new marketing authorisation using the variation C.I.104 Typ IB.
Dr. Katharina Oehler
Scientific and Managing Director
Send email